Pharmacoepidemiology Seminars and Speakers, 1998-1999



The Pharmacoepidemiology Lecture Series is sponsored by the Department of Epidemiology through Dr. Walker.  The purpose of the  Pharmacoepidemiology Lecture Series is to invite distinguished lecturers to HSPH who are working in an academic, industry or government environment, whose work/research focuses on the epidemiology of drug utilization and the intended and unintended effects of pharmaceutical and medical procedures.

LOCATION:       Epidemiology Library
                            Harvard School of Public Health
                            677 Huntington Avenue
                            Room  904, Kresge Building
                            Boston, MA 02115

TIME:                  12:30-1:30

Do you want to be included in a mailing list on upcoming events?


This is still a tentative list. Please check this page for confirmations and changes.

Oct. 21, 1998          Dr. Arnold Chan,
                                Ass. Professor, Pharmacoepidemiology
                                Dept. of Epidemiology, Harvard School of Public Health
                                'Pharmacoepidemiology and Drug Safety in East Asia'

Nov. 18, 1998         Dr. Phillip Sarocco,
                                Director of Health Economics, Parke-Davis
                                'Application of Pharmacoepidemiology and Economic
                                Modeling: Target T2 Model in Type 2 Diabetes Mellitus'

Dec. 16, 1998         Dr. Sheldon Kong,
                               Director, Outcomes Research, Merck&Co
                               'Collaboration on Outcomes Research among Academic Researchers,
                               Managed Care Organizations, and Pharmaceutical Manufacturers'

Feb 17, 1999          Dr. Robert Glynn
                               Assoc. Prof.
                               Division of Pharmacoepidemiology and Pharmacoeconomics,
                               Harvard Medical School
                               'Agreement between Drug Treatment and Discharge
                               Diagnosis of Diabetes'

Mar 17, 1999         Dr. Stanley Garbus,
                               President and Chief Medical Officer, Global Safety Surveillance Inc.
                               'The Real World of Pharmacovigilance: Managing Product Safety
                               to minimize Corporate Risk'

Mar 31, 1999         Dr. Richard Platt
                               Assoc. Prof.
                               Depts. of Ambulatory Care and Prevention, and Medicine
                               Harvard Medical School

Apr 21, 1999          Dr. Paul Grootendorst
                               Ass. Professor, Health Economics
                               Centre for Evaluation of Medicine, McMaster University

May 13, 1999         Dr. Albert J. Jovell
                               Executive Director
                               Fundacio Biblioteca Josep Laporte, University Autonoma of Barcelona
                               Associate Professor, University Autonoma of Barcelona
                               Associate Researcher, Catalan Agency for Health Technology Assessment
                               'Is Evidence-Based Medicine the Magic Bullet for Preventive
                                and Clinical Decision-Making?'
 

May 19, 1999         Dr. Alexander Walker
                               Professor of Epidemiology
                               Chairman, Dept. of Epidemiology, Harvard School of Public Health
 
 
 



Do you want to be included in a mailing list on upcoming events?

Please send an e-mail to:                  majordomo@hsphsun2.harvard.edu
                Message text:                    subscribe pharmepi
                                                                        Note: no subject, no other text


If you have questions or comments about the Seminars,  please send an e-mail to Linda Marc

Return to the top of this document

Return to DDIL HOMEPAGE

This document has been provided through the Drugs and Devices Information Line, http://www.hsph.harvard.edu/Organizations/DDIL/ddil.html
If you have questions or comments about the DDIL, please write to: sschneew@hsph.harvard.edu